The invention concerns a novel phosphoglycolipid compound. The compound of the subject invention is 2- Deoxy-6-O- [2-deoxy-4-O -phosphono-3-O -[(R)-3- tetradecanoyloxytetradecanoyl] -2-[(R)-3- octadecanoyloxytetradecanoylamino] -β-D-glucopyranosyl] -2-[(R)-3- hexadecanoyloxytetradecanoylamino] -D-glucopyranose and pharmaceutically acceptable salts thereof. The compound is not immunoreactive, not pyrogenic, not toxic but is active in ameliorating tissue damage due to ischemia/reperfusion injury. Methods for using the subject compound to protect against reversible and irreversible damage due to ischemia/reperfusion injury are also disclosed.
该发明涉及一种新型的
磷酸甘油脂化合物。该发明的化合物是2-去氧-6-O-[2-去氧-4-O-
磷酸-3-O-[(R)-3-十
四酸酰氧基-十
四酸酰] -2-[(R)-3-
十八酸酰氧基-十
四酸酰胺]-β-
D-葡萄糖吡喃糖基]-2-[(R)-3-
十六酸酰氧基-十
四酸酰胺]-
D-葡萄糖吡喃糖和其药学上可接受的盐。该化合物不具有免疫反应性、不具有致热原性、不具有毒性,但在改善因缺血/再灌注损伤引起的组织损伤方面具有活性。还公开了使用该化合物保护可逆和不可逆缺血/再灌注损伤引起的损伤的方法。